IT Digital Health Platform Technical Lead at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

High School Diploma/GED with 10+ years of hands-on technical experience with modern cloud and web technologies OR Bachelor’s Degree in computer science, engineering, or related discipline
7+ years of experience delivering software solutions that span the development lifecycle (e.g., design, development, testing, deployment, and support)
5+ years of technical leadership experience in delivery of software projects
Legally authorized to be employed in the United States (no sponsorship anticipated)

Responsibilities

Develop and drive adoption of platform development standards and architecture patterns across the organization
Enable technical delivery of SPE software components including understanding and addressing risk, privacy, cybersecurity and legal constraints on project delivery
Drive design of new feature requests that are highly scalable and resilient
Align SPE technical solutions with Lilly supported technologies
Provide technical evaluation of proposed project ideas, software changes and future product releases
Drive the development and execution of our platform innovation roadmap, including creating working proof of concept models in new technology spaces directly connected to future Software Product Engineering capabilities
Mentor more junior members of the technical team
Build effective relationships with key technical resources and architects to influence technology solutions specifically related to Software Product Engineering systems
Provide guidance to Lilly and non-Lilly software delivery teams in best practice Agile delivery of software components of Lilly’s platform
Obtain and use knowledge of medical device delivery models and quality system to ensure solutions align with regulatory expectations and meet regulatory timelines
Obtain and bring to bear knowledge of Lilly business processes and technology to ensure solution deliveries are consistent with the strategy and roadmap

Skills

Platform Architecture

Software Engineering

Digital Health Platforms

Medical Device Regulations

Technical Leadership

Data Analytics

Connected Solutions

Regulatory Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free